|
Volumn 51, Issue 2, 2012, Pages 132-133
|
Cautious reassurance: Cardiovascular risk in the context of stimulant use
|
Author keywords
[No Author keywords available]
|
Indexed keywords
AMPHETAMINE;
CENTRAL STIMULANT AGENT;
METHYLPHENIDATE;
ATTENTION DEFICIT DISORDER;
BEHAVIOR THERAPY;
CARDIOVASCULAR DISEASE;
CARDIOVASCULAR RISK;
DIASTOLIC BLOOD PRESSURE;
DRUG SURVEILLANCE PROGRAM;
EDITORIAL;
FOOD AND DRUG ADMINISTRATION;
HEART INFARCTION;
HUMAN;
INSURANCE;
MORTALITY;
PATIENT COMPLIANCE;
PRESCRIPTION;
PRIORITY JOURNAL;
RANDOMIZED CONTROLLED TRIAL (TOPIC);
RISK ASSESSMENT;
SIDE EFFECT;
STROKE;
SUDDEN DEATH;
SYSTOLIC BLOOD PRESSURE;
TACHYCARDIA;
ANIMALS;
FEMALE;
MALE;
METHOXAMINE;
NEURONS;
PRAZOSIN;
SPINAL CORD;
SYMPATHETIC NERVOUS SYSTEM;
|
EID: 84855998186
PISSN: 08908567
EISSN: 15275418
Source Type: Journal
DOI: 10.1016/j.jaac.2011.11.013 Document Type: Editorial |
Times cited : (1)
|
References (10)
|